Pinnacle Bancorp’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $132K | Hold |
2,289
| – | – | 0.03% | 306 |
|
|
2026
Q1 | $139K | Hold |
2,289
| – | – | 0.04% | 282 |
|
|
2025
Q4 | $123K | Sell |
2,289
-500
| -18% | -$24.1K | 0.04% | 298 |
|
|
2025
Q3 | $126K | Hold |
2,789
| – | – | 0.04% | 296 |
|
|
2025
Q2 | $129K | Sell |
2,789
-100
| -3% | -$4.91K | 0.04% | 289 |
|
|
2025
Q1 | $176K | Sell |
2,889
-287
| -9% | -$16.7K | 0.06% | 236 |
|
|
2024
Q4 | $180K | Buy |
3,176
+600
| +23% | +$33.5K | 0.06% | 231 |
|
|
2024
Q3 | $133K | Hold |
2,576
| – | – | 0.04% | 259 |
|
|
2024
Q2 | $107K | Sell |
2,576
-750
| -23% | -$33.6K | 0.03% | 267 |
|
|
2024
Q1 | $180K | Buy |
3,326
+565
| +20% | +$28.8K | 0.05% | 216 |
|
|
2023
Q4 | $142K | Buy |
2,761
+247
| +10% | +$13K | 0.05% | 229 |
|
|
2023
Q3 | $146K | Sell |
2,514
-950
| -27% | -$58.2K | 0.05% | 213 |
|
|
2023
Q2 | $222K | Buy |
3,464
+100
| +3% | +$6.71K | 0.08% | 178 |
|
|
2023
Q1 | $233K | Hold |
3,364
| – | – | 0.09% | 175 |
|
|
2022
Q4 | $242K | Buy |
3,364
+55
| +2% | +$4.15K | 0.09% | 165 |
|
|
2022
Q3 | $235K | Sell |
3,309
-102
| -3% | -$7.4K | 0.1% | 148 |
|
|
2022
Q2 | $263K | Buy |
3,411
+1,429
| +72% | +$109K | 0.11% | 134 |
|
|
2022
Q1 | $145K | Buy |
1,982
+146
| +8% | +$9.8K | 0.05% | 207 |
|
|
2021
Q4 | $114K | Hold |
1,836
| – | – | 0.04% | 232 |
|
|
2021
Q3 | $109K | Buy |
1,836
+174
| +10% | +$11.5K | 0.04% | 232 |
|
|
2021
Q2 | $111K | Sell |
1,662
-219
| -12% | -$14.3K | 0.05% | 228 |
|
|
2021
Q1 | $119K | Sell |
1,881
-45
| -2% | -$2.8K | 0.06% | 210 |
|
|
2020
Q4 | $119K | Hold |
1,926
| – | – | 0.07% | 206 |
|
|
2020
Q3 | $116K | Sell |
1,926
-185
| -9% | -$11.1K | 0.08% | 184 |
|
|
2020
Q2 | $124K | Hold |
2,111
| – | – | 0.09% | 175 |
|
|
2020
Q1 | $118K | Hold |
2,111
| – | – | 0.1% | 167 |
|
|
2019
Q4 | $136K | Buy |
2,111
+625
| +42% | +$35.8K | 0.09% | 176 |
|
|
2019
Q3 | $75K | Sell |
1,486
-522
| -26% | -$24.5K | 0.04% | 240 |
|
|
2019
Q2 | $91K | Sell |
2,008
-100
| -5% | -$4.66K | 0.05% | 219 |
|
|
2019
Q1 | $101K | Sell |
2,108
-609
| -22% | -$30.3K | 0.06% | 201 |
|
|
2018
Q4 | $141K | Buy |
+2,717
| New | +$146K | 0.09% | 160 |
|
|
2017
Q1 | $255K | Buy |
+4,694
| New | +$257K | 0.18% | 85 |
|
Other funds holding BMY
Pinnacle Bancorp's BMY Position: Q2 2026 in Review
Pinnacle Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 2,289 shares worth $132K. The position accounts for 0.03% of the portfolio, ranked #306.
Pinnacle Bancorp first reported a position in BMY in Q1 2017 and has held it in 32 quarters since. The position peaked at $263K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Pinnacle Bancorp held 2,289 shares of Bristol-Myers Squibb worth $132K as of Q2 2026.
- Pinnacle Bancorp left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.03% of Pinnacle Bancorp's portfolio in Q2 2026, its #306 holding.
- Pinnacle Bancorp first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 32 quarters since.
- Pinnacle Bancorp's Bristol-Myers Squibb position peaked at $263K in Q2 2022.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.